Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 36, No. 1, 2011
Issue release date: February 2011
Section title: Original Paper
Free Access
Neuroepidemiology 2011;36:46–51

Patterns of Mind-Body Therapies in Adults with Common Neurological Conditions

Erwin Wells R.a · Phillips R.S.b · McCarthy E.P.b
aDepartment of Neurology and bDivision of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass., USA
email Corresponding Author

Rebecca Erwin Wells, MD

Department of Neurology

Beth Israel Deaconess Medical Center, Harvard Medical School

330 Brookline Avenue, Boston, MA 02215 (USA)

Tel. +1 617 632 8917, Fax +1 617 632 8920, E-Mail rwells@bidmc.harvard.edu

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: Over 40% of adults with common neurological conditions use complementary and alternative medicine, and mind-body therapies are the most commonly used form. Our objective was to describe mind-body use in adults with common neurological conditions. Methods: We compared mind-body use between adults with and without common neurological conditions (regular headaches, migraines, back pain with sciatica, strokes, dementia, seizures or memory loss) using the 2007 National Health Interview Survey of 23,393 sampled American adults. Results: Adults with common neurological conditions used mind-body therapies more frequently than those without (24.5 vs. 16.6%, p < 0.0001); differences persisted after adjustment. Deep breathing exercises, meditation and yoga were used most frequently. Nearly 70% of the adults with common neurological conditions did not discuss their mind-body use with their health care provider. Those with neurological conditions used mind-body therapies more than those without these conditions because of provider recommendation (26 vs. 13%) or because conventional treatments were perceived ineffective (12 vs. 4%) or too costly (7 vs. 2%), respectively. Conclusions: Mind-body therapies are used more frequently among adults with common neurological conditions, more often when conventional treatments were perceived ineffective. More research is warranted on the efficacy of mind-body use for common neurological conditions.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: July 29, 2010
Accepted: November 22, 2010
Published online: December 22, 2010
Issue release date: February 2011

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 1

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: http://www.karger.com/NED

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.